Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

ImmunoGen, Inc. Moves Forward

TheMotleyFool

0 0

Like most biotechs without a drug generating revenue, ImmunoGen's (NASDAQ: IMGN) third-quarter earnings were a review of what it's accomplished and a look at what investors can expect in the future.

Fortunately, it's been a productive year for the company in terms of shoring up its balance sheet. Unfortunately, investors still have a ways to go before the revenue will start rolling in.

Metric

Source: Fool.com